Do topical formulations of novel angiostatic steroids inhibit rabbit corneal neovascularization?
The antiangiogenic steroid AL-3789 may be a therapeutically useful angiostatic agent for corneal neovascularization and potentially could be effective in other ocular neovascular diseases.
Current meta-analysis suggested that high intake of cholesterol was positively associated with future T2D risk.